Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/30915

Title:	Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.
Authors:	Cavero-Redondo, Iván Peleteiro, Barbara Álvarez-Bueno, Celia Rodriguez-Artalejo, Fernando Martínez-Vizcaíno, Vicente View more
Keywords:	All-cause mortality Cardiovascular mortality HbA1c Meta-analysis View more
Mesh:	Cardiovascular Diseases Diabetes Mellitus, Type 2 Glycated Hemoglobin A Humans Observational Studies as Topic Risk Factors View more
Issue Date:	31-Jul-2017
Citation:	BMJ Open.2017 Jul;(7)7:e015949
Abstract:	To examine the relationship between glycated haemoglobin A1c (HbA1c) levels and the risk of cardiovascular outcomes and all-cause mortality based on data from observational studies and to determine the optimal levels of HbA1c for preventing cardiovascular events and/or mortality in diabetic and non-diabetic populations.
PMID:	28760792
URI:	https://hdl.handle.net/20.500.12530/30915
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC5642750.pdf		1.31 MB	Adobe PDF	View/Open